Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral type 2 cannabinoid receptor. (2017)

First Author: Marino S

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.phrs.2017.02.023

PubMed Identifier: 28274851

Publication URI: http://europepmc.org/abstract/MED/28274851

Type: Journal Article/Review

Volume: 119

Parent Publication: Pharmacological research

ISSN: 1043-6618